Neurophysiological evaluation in children with Friedreich's ataxia

Early Human Development

Volumn 85, Issue 10, 2009, Pages 647-651

  Sival, D A ^a   du Marchie Sarvaas, G J ^a   Brouwer, O F ^a   Uges, D R ^a   Verschuuren Bemelmans, C C ^a   Maurits, N M ^a   Brunt, E R ^a   van der Hoeven, J H ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Cardiomyopathy; Child; Friedreich's Ataxia; ICARS; Muscle force; Neuropathy; Neurophysiology

Indexed keywords

IDEBENONE;

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DYNAMOMETRY; EVOKED SOMATOSENSORY RESPONSE; FRIEDREICH ATAXIA; GENETIC ANALYSIS; HUMAN; LEG MUSCLE; MUSCLE FORCE; NERVE CONDUCTION; NEUROPHYSIOLOGY; PERONEUS NERVE; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; ANTIOXIDANTS; CHILD; EVOKED POTENTIALS, SOMATOSENSORY; FRIEDREICH ATAXIA; HUMANS; LONGITUDINAL STUDIES; MUSCLE STRENGTH DYNAMOMETER; NEURAL CONDUCTION; TREATMENT OUTCOME; UBIQUINONE;

EID: 70350052560     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2009.09.002     Document Type: Article

References (31)

1. Harding A.E. Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104 3 (1981) 589-620
2. Ackroyd R.S., Finnegan J.A., and Green S.H. Friedreich's ataxia. A clinical review with neurophysiological and echocardiographic findings. Arch Dis Child 59 3 (1984) 217-221
3. Dunn H.G. Nerve conduction studies in children with Friedreich's ataxia and ataxia-telangiectasia. Dev Med Child Neurol 15 3 (1973) 324-337
4. Rotig A., de L.P., Chretien D., Foury F., Koenig M., Sidi D., et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 17 2 (1997) 215-217
5. Alper G., and Narayanan V. Friedreich's ataxia. Pediatr Neurol 28 5 (2003) 335-341
6. Durr A., Cossee M., Agid Y., Campuzano V., Mignard C., Penet C., et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 335 16 (1996) 1169-1175
7. Buyse G., Mertens L., Di S.G., Matthijs I., Weidemann F., Eyskens B., et al. Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring. Neurology 60 10 (2003) 1679-1681
8. Rustin P., von Kleist-Retzow J.C., Chantrel-Groussard K., Sidi D., Munnich A., and Rotig A. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 354 9177 (1999) 477-479
9. Mariotti C., Solari A., Torta D., Marano L., Fiorentini C., and Di D.S. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial. Neurology 60 10 (2003) 1676-1679
10. English K.M., and Gibbs J.L. Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders. Dev Med Child Neurol 48 3 (2006) 231-235
11. Di Prospero N.A., Baker A., Jeffries N., and Fischbeck K.H. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Lancet Neurol 6 10 (2007) 878-886
12. Pineda M., Arpa J., Montero R., Aracil A., Dominguez F., Galvan M., et al. Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up. Eur J Paediatr Neurol 12 6 (2008) 470-475
13. Artuch R., Aracil A., Mas A., Colome C., Rissech M., Monros E., and Pineda M. Friedreich's ataxia: idebenone treatment in early stage patients. Neuropediatrics 33 4 (2002) 190-193
14. Ribai P., Pousset F., Tanguy M.L., Rivaud-Pechoux S., Le B., Gasparini I.F., et al. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up. Arch Neurol 64 4 (2007) 558-564
15. Schols L., Vorgerd M., Schillings M., Skipka G., and Zange J. Idebenone in patients with Friedreich ataxia. Neurosci Lett 306 3 (2001) 169-172
16. Sival D.A., and Brunt E.R. The International Cooperative Ataxia Rating Scale shows strong age-dependency in children. Dev Med Child Neurol 51 7 (2009) 571-572
17. Largo R.H., Caflisch J.A., Hug F., Muggli K., Molnar A.A., and Molinari L. Neuromotor development from 5 to 18 years. Part 2: associated movements. Dev Med Child Neurol 43 7 (2001) 444-453
18. Largo R.H., Caflisch J.A., Hug F., Muggli K., Molnar A.A., Molinari L., et al. Neuromotor development from 5 to 18 years. Part 1: timed performance. Dev Med Child Neurol 43 7 (2001) 436-443
19. Cano S.J., Hobart J.C., Hart P.E., Korlipara L.V., Schapira A.H., and Cooper J.M. International Cooperative Ataxia Rating Scale (ICARS): appropriate for studies of Friedreich's ataxia?. Mov Disord 20 12 (2005) 1585-1591
20. Trouillas P., Takayanagi T., Hallett M., Currier R.D., Subramony S.H., Wessel K., et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 145 2 (1997) 205-211
21. van de Wassenberg W.J.G., van der Hoeven J.H., Leenders K.L., and Maurits N.M. Multichannel recording of median nerve somatosensory evoked potentials. Neurophysiol Clin 38 1 (2008) 9-21
22. Levy S.R. Somatosensory evoked potentials in pediatrics. In: Chiappa K.H. (Ed). Evoked potentials in clinical medicine: methodology (1997), Raven Press, New York 453-471
23. Kimura J. Assessment of individual nerves. Electrodiagnosis in diseases of nerve and muscle: principles and practice (1981), F.A. Davis Company, Philadelphia 103-135
24. Beenakker E.A., van der Hoeven J.H., Fock J.M., and Maurits N.M. Reference values of maximum isometric muscle force obtained in 270 children aged 4-16 years by hand-held dynamometry. Neuromuscul Disord 11 5 (2001) 441-446
25. Rauh M., and Koch A. Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children. Clin Chem 49 9 (2003) 1563-1564
26. Henry W.L., Gardin J.M., and Ware J.H. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 62 5 (1980) 1054-1061
27. Babcock M., de S.D., Oaks R., Davis-Kaplan S., Jiralerspong S., Montermini L., et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 276 5319 (1997) 1709-1712
28. Vorgerd M., Schols L., Hardt C., Ristow M., Epplen J.T., and Zange J. Mitochondrial impairment of human muscle in Friedreich ataxia in vivo. Neuromuscul Disord 10 6 (2000) 430-435
29. Said G., Marion M.H., Selva J., and Jamet C. Hypotrophic and dying-back nerve fibers in Friedreich's ataxia. Neurology 36 10 (1986) 1292-1299
30. Beauchamp M., Labelle H., Duhaime M., and Joncas J. Natural history of muscle weakness in Friedreich's Ataxia and its relation to loss of ambulation. Clin Orthop Relat Res 311 (1995) 270-275
31. De Castro M., Garcia-Planells J., Monros E., Canizares J., Vazquez-Manrique R., Vilchez J.J., et al. Genotype and phenotype analysis of Friedreich's ataxia compound heterozygous patients. Hum Genet 106 1 (2000) 86-92